IQVIA Holdings (FRA:QTS) ROCE %: 9.75% (As of Mar. 2026)


FRA:QTS IQVIA Holdings Inc FRA:QTS
88 GF Score
Price €164.25
GF Value €219.41
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is IQVIA Holdings ROCE %?

IQVIA Holdings FRA:QTS -0.09% 88 ROCE % is 9.75% as of Mar. 2026. GuruFocus rates FRA:QTS with a GF Score™ of 88/100 and a GF Value™ of €219.41 (Modestly Undervalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. IQVIA Holdings's annualized ROCE % for the quarter that ended in Mar. 2026 was 9.75%.

IQVIA Holdings  (FRA:QTS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

IQVIA Holdings ROCE % Related Terms

IQVIA Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for IQVIA Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings ROCE % Chart

IQVIA Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.90 9.37 10.52 11.89 10.57

IQVIA Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.58 9.49 11.47 13.98 9.75
FRA:QTS
88GF Score
IQVIA Holdings Inc FRA:QTS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IQVIA Holdings ROCE % Calculation

IQVIA Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=1981.28/( ( (25688.545 - 6643.935) + (25572.176 - 7120.652) )/ 2 )
=1981.28/( (19044.61+18451.524)/ 2 )
=1981.28/18748.067
=10.57 %

IQVIA Holdings's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=1799.2/( ( (25572.176 - 7120.652) + (25668.875 - 7204.585) )/ 2 )
=1799.2/( ( 18451.524 + 18464.29 )/ 2 )
=1799.2/18457.907
=9.75 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 9.75% mean?
IQVIA Holdings (FRA:QTS) has a ROCE % of 9.75% as of Mar. 2026.
Is IQVIA Holdings' ROCE % too high?
IQVIA Holdings' current ROCE % is 9.75%. Overall, IQVIA Holdings has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IQVIA Holdings' ROCE % compare to NTRA and ILMN?
IQVIA Holdings' ROCE % of 9.75% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Diagnostics & Research company?
A good ROCE % depends on the Medical Diagnostics & Research industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. IQVIA Holdings's current ROCE % is 9.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IQVIA Holdings stock overvalued right now?
Based on GuruFocus' analysis, IQVIA Holdings (FRA:QTS) is currently considered Modestly Undervalued. The stock's GF Value™ is €219.41, compared to a current price of €164.25 — trading 25.1% below its estimated fair value. The current ROCE % is 9.75%. IQVIA Holdings' overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For IQVIA Holdings (FRA:QTS), the current ROCE % is 9.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IQVIA Holdings (FRA:QTS) Overvalued in 2026?

Based on GuruFocus' analysis, IQVIA Holdings stock appears to be undervalued. The current stock price of €164.25 is trading 25.1% below its estimated GF Value™ of €219.41. GuruFocus considers IQVIA Holdings to be Modestly Undervalued.

Key valuation signals for FRA:QTS:

  • ROCE %: 9.75%
  • GF Value™: €219.41 vs. price of €164.25 (25.1% below fair value)
  • GF Score™: 88/100 with 3 warning signs

No single metric tells the full story. See the FRA:QTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IQVIA Holdings Business Description

Address 2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
88GF Score

Get the complete analysis for FRA:QTS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€164.25
Price
€219.41
GF Value